The New Frontier of Combination Therapy for IBD: The VEGA RCT
Evidence-Based GI: An ACG Publication and Podcast - Een podcast door American College of Gastroenterology - Woensdagen
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial,” by Feagan BG, Sands BE, Sandborn WJ, et al. Lancet Gastroenterol Hepatol. 2023; 8: 307-20.
